ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation

Borenas, M; Umapathy, G; Lai, WY; Lind, DE; Witek, B; Guan, JK; Mendoza-Garcia, P; Masudi, T; Claeys, A; Chuang, TP; El Wakil, A; Arefin, B; Fransson, S; Koster, J; Johansson, M; Gaarder, J; Van den Eynden, J; Hallberg, B; Palmer, RH

Hallberg, B; Palmer, RH (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.; Van den Eynden, J (corresponding author), Univ Ghent, Dept Human Struct & Repair, Anat & Embryol Unit, Ghent, Belgium.

EMBO JOURNAL, 2021; 40 (3):

Abstract

High-risk neuroblastoma (NB) is responsible for a disproportionate number of childhood deaths due to cancer. One indicator of high-risk NB is amplific......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索